When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA considers adding a dozen peptides to its bulk drug compounding list RAPS BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved HIMS $LLY $NVO The FDA will discuss 7 peptides for possible inclusion on the 503A Bulks List on July 23 24: BPC 157 KPV TB 500 MOTs C Emideltide Semax